Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Sharon M. Moe,Tilman B. Drüeke,John Cunningham,Wayne K. Goodman,Kevin J. Martin,Klaus Olgaard,Susan M. Ott,Stuart M. Sprague,Norbert Lameire,Garabed Eknoyan +9 more
1.8K
TL;DR: It is recommended that the term renal osteodystrophy be used exclusively to define alterations in bone morphology associated with CKD, and the term CKD-Mineral and Bone Disorder (CKD-MBD) be used to describe a broader clinical syndrome that develops as a systemic disorder of mineral and bone metabolism due to CKD.
read more
About: This article is published in Kidney International. The article was published on 01 Jun 2006. and is currently open access. The article focuses on the topics: Chronic kidney disease-mineral and bone disorder & Renal osteodystrophy.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Bone Turnover, Mineralization, and Volume Estimated by 18F-Sodium Fluoride PET/CT and Biomarkers in Chronic Kidney Disease: Mineral and Bone Disorder Compared with Bone Biopsy
M. H. Vrist,Ann Mai Østergaard,Stine Langaa,Frank H Mose,Claire Fynbo,Jørn Theil,Bente L. Langdahl,Thomas G. Lauridsen,Jesper N. Bech +8 more
TL;DR: 18F-NaF PET/CT may be applicable for noninvasive assessment of bone turnover and volume in CKD-MBD and only osteocalcin showed a correlation with turnover assessed by histomorphometry.
6
Prescription Practices in Patients With Mild to Moderate CKD in India.
Narayan Prasad,Ashok Kumar Yadav,Monica Kundu,Jasmin Sethi,Ajay Jaryal,D. Sircar,Gopesh K. Modi,K. Kamboj,Manisha Sahay,Natarajan Gopalakrishnan,Prabhjot Kaur,Sanjay Vikrant,Santosh Varughese,Seema Baid-Agrawal,Shivendra Singh,Sishir Gang,Sreejith Parameswaran,Vivek Kumar,Arpita Ghosh,Vivekanand Jha,Vivekanand Jha,Vivekanand Jha +21 more
TL;DR: In this paper, the authors describe the drug prescription practices in patients with mild to moderate chronic kidney disease (CKD) using baseline data from the Indian CKD (ICKD) cohort, and evaluate the appropriateness of medication use.
6
External auditory canal cholesteatoma with chronic renal failure or hemodialysis
TL;DR: Six out of all 9 EACC cases with CRF developed bilaterally, and in the inferior or posterior inferior part of the EAC, which implies a common pathological condition that contributes to the development of EACC.
6
Diagnosis of Renal Osteodystrophy
TL;DR: The search continues for a specific and sensitive biochemical marker for monitoring bone turnover in CKD, e.g., alkaline phosphatase, osteocalcin, collagen degradation products, etc.
6
Dietary intakes and some biochemical markers in hemodialysis patients
TL;DR: HD patients often have low protein and energy intakes and most of them suffer from malnutrition, so nutritional status of patients should be evaluated and periodically nutrition education should be given for improving eating habits and increasing dietary compliance.
References
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
A. Michael Parfitt,Marc K. Drezner,Francis H. Glorieux,John A. Kanis,Hartmut H. Malluche,Pierre J. Meunier,Susan M. Ott,Robert R. Recker +7 more
TL;DR: A committee of the Society to develop a unified system of termnology, suitable for adoption by the Journal of Bone and Mineral Research as part of its Instructions to Authors is formed, and is as complex and conceptually difficult as the field with which it deals.
5.4K
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Andrew S. Levey,Kai-Uwe Eckardt,Yusuke Tsukamoto,Adeera Levin,Josef Coresh,Jerome Rossert,Dick de Zeeuw,Thomas H. Hostetter,Norbert Lameire,Garabed Eknoyan +9 more
TL;DR: A survey and conference was conducted and a controversies conference was sponsored to provide a clear understanding to both the nephrology and nonnephrology communities of the evidence base for the definition and classification recommended by Kidney Disease Quality Outcome Initiative (K/DOQI).
3.9K
•Journal Article
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Shaul G. Massry,Jack W. Coburn,Glenn M. Chertow,Keith A. Hruska,Craig B. Langman,Hartmut H. Malluche,Kevin J. Martin,Linda McCann,James T. McCarthy,Sharon M. Moe,Isidro B. Salusky,Donald J. Sherrand,Miroslaw Smogorzewski,Kline Bolton,Charles Turkelson,Karyn A. Tappe,Stephen Tregear,James Reston,Wendy Bruening,Mark Monteforte,Janice Kaczmarek,Vivian Coates,George R. Bailie,Bryan N. Becker,Gavin J. Becker,Jerrilynn D. Burrowes,Fernando Carrera,David N. Churchill,Allan J. Collins,Peter W. Crooks,Dick DeZeeuw,Thomas A. Golper,Frank A. Gotch,Antonio M. Gotto,Roger Greenwood,Joel W. Greer,Richard H. Grimm,William E. Haley,Ronald J. Hogg,Alan R. Hull,Lawrence G. Hunsicker,Cynda Ann Johnson,Michael J. Klag,Saulo Klahr,Norbert Lameire,Francesco Locatelli,Sally McCulloch,Maureen Michael,Joseph V. Nally,John M. Newmann,Allen R. Nissenson,Keith C. Norris,Gregorio T. Obrador,William F. Owen,Thakor G. Patel,Glenda Payne,Claudio Ronco,Rosa A. Rivera-Mizzoni,Anton C. Schoolwerth,Robert A. Star,Michael W. Steffes,Theodore I. Steinman,John Pierre Wauters,Nanette K. Wenger,Josephine P. Briggs,Thomas H. Hostetter,Garabed Eknoyan,Aderra Levin,Nathan W. Levin,Sharon Andreoli,Sally Burrows-Hudson,Derrick Latos,Donna Mapes,Edith Oberley,Brian J.G. Pereira,Nadine Ferguson,Donna Fingerhut,Anthony Gucciardo,Margaret Klette,Doreen Mallard,Kerry Willis +80 more
2.8K
Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality
Gérard M. London,Alain P. Guerin,Sylvain J. Marchais,Fabien Metivier,Bruno Pannier,Hasan Adda +5 more
TL;DR: AMC is a strong prognostic marker of all-cause and CV mortality in HD patients, independently of classical atherogenic factors and the principal effect of AMC on arterial function is increased arterial stiffness.
Related Papers (5)
Shaul G. Massry,Jack W. Coburn,Glenn M. Chertow,Keith A. Hruska,Craig B. Langman,Hartmut H. Malluche,Kevin J. Martin,Linda McCann,James T. McCarthy,Sharon M. Moe,Isidro B. Salusky,Donald J. Sherrand,Miroslaw Smogorzewski,Kline Bolton,Charles Turkelson,Karyn A. Tappe,Stephen Tregear,James Reston,Wendy Bruening,Mark Monteforte,Janice Kaczmarek,Vivian Coates,George R. Bailie,Bryan N. Becker,Gavin J. Becker,Jerrilynn D. Burrowes,Fernando Carrera,David N. Churchill,Allan J. Collins,Peter W. Crooks,Dick DeZeeuw,Thomas A. Golper,Frank A. Gotch,Antonio M. Gotto,Roger Greenwood,Joel W. Greer,Richard H. Grimm,William E. Haley,Ronald J. Hogg,Alan R. Hull,Lawrence G. Hunsicker,Cynda Ann Johnson,Michael J. Klag,Saulo Klahr,Norbert Lameire,Francesco Locatelli,Sally McCulloch,Maureen Michael,Joseph V. Nally,John M. Newmann,Allen R. Nissenson,Keith C. Norris,Gregorio T. Obrador,William F. Owen,Thakor G. Patel,Glenda Payne,Claudio Ronco,Rosa A. Rivera-Mizzoni,Anton C. Schoolwerth,Robert A. Star,Michael W. Steffes,Theodore I. Steinman,John Pierre Wauters,Nanette K. Wenger,Josephine P. Briggs,Thomas H. Hostetter,Garabed Eknoyan,Aderra Levin,Nathan W. Levin,Sharon Andreoli,Sally Burrows-Hudson,Derrick Latos,Donna Mapes,Edith Oberley,Brian J.G. Pereira,Nadine Ferguson,Donna Fingerhut,Anthony Gucciardo,Margaret Klette,Doreen Mallard,Kerry Willis +80 more